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Abstract
Background: The medical management of aggressive and violent behaviour is a critical situation
for which there is little evidence. In order to prepare for a randomised trial, due to start in the
psychiatric emergency rooms of Rio de Janeiro in 2001, a survey of current practice was necessary.
Methods: A seven day survey of pharmacological management of aggressive people with psychosis
in the emergency rooms of all four public psychiatric hospitals in Rio de Janeiro, Brazil.
Results: In one hospital data were not available. Of the 764 people with psychosis attending these
ERs, 74 were given IM medication for rapid tranquillisation (9.7%, 2.1/week/100,000). A
haloperidol-promethazine mix (with or without other drugs) was used for the majority of patients
(83%).
Conclusion: The haloperidol-promethazine mix, given intramuscularly for rapid tranquilization, is
prevalent in Rio, where it is considered both safe and efficient. However, scientific evaluation of all
pharmacological approaches to rapid tranquilization of psychotic people is inadequate or
incomplete and a randomized trial of IM haloperidol-promethazine is overdue.
Background
Agitated or violent patients constitute 10% of all emergen-
cy psychiatric treatment [8]. The majority of these people
have severe psychiatric problems such as schizophrenia,
affective disorder or substance abuse[8]. Less frequently,
organic illness or serious psychological stresses underlie
the aggression. The medical management of aggressive
and violent behavior by people with schizophrenia or
other serious mental illnesses is of continuing central con-
cern to clinicians [2].
In order to gain an overview of the evidence underlying
current practice, the authors first undertook a search of the
Cochrane Library. The search strategies used for all data-
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bases mentioned are available from the authors. Relevant
randomised clinical trials seem few, small and of debata-
ble clinical utility [19]. For example, we found only one
randomised trial (n = 40) comparing haloperidol (IV)
with placebo for acutely disturbed psychiatric patients
[14]. Only one statistically significant difference was
found (RR unimproved by 2 hours 0.19 95% CI 0.04 to
0.9). A very small (n = 12) randomised trial compared
benzodiazepines with placebo for acutely disturbed peo-
ple [11], and, unsurprisingly, found no clear differences.
Seven trials (total n = 206), compared benzodiazepines
versus typical antipsychotics[9]. Benzodiazepines are sta-
tistically significantly more likely to produce an 'improve-
ment' by 1.5 hours (RR 1.6 95% CI 1.02 to 2.5), but
patients may also be at greater risk of needing additional
injections (RR 0.66 95% CI 0.42 to 1.02). On the other
hand, more patients given haloperidol are asleep by three
hours than those allocated to benzodiazepines (RR 1.6
95% CI 0.99 to 2.5). Ninety-six people were randomised
to trials investigating the value of a benzodiazepine-ha-
loperidol mix versus haloperidol alone for acutely dis-
turbed people [9]. The combination, largely with
lorazepam, is no better than haloperidol for all the out-
comes measured (eg. unimproved by 1.5 hours RR 0.7
95% CI 0.3 to 1.7), except for being asleep by 3 hours, fa-
vouring the mix (RR 2.0 95% CI 1.1 to 3.5). A systematic
review of droperidol for acutely disturbed people, now
withdrawn from use because of cardiac problems with pro-
longed use, shows it to be of unclear advantage when com-
pared with placebo (1 RCT, n = 41, RR needing additional
injection by 30 minutes 0.46 95% CI 0.2 to 1.2) or ha-
loperidol (1RCT, n = 27, RR needing additional injection
by 30 minutes 0.45 95% CI 0.2 to 1.01) [5]. A systematic
review of zuclopenthixol acetate (5 RCTs, total n = 413),
found no statistically significant differences for outcomes
such as 'not sedated by two hours' (RR 0.6 95% CI 0.3 to
1.3) and 'needing another injection' (RR 1.5 95% CI 0.8
to 2.9), when compared to haloperidol, chlorpromazine
or clothiapine[6].
With such limited evidence it is understandable that doc-
tors may differ in their choice of drugs. We then sought
surveys of the opinion of clinicians in MEDLINE and Psy-
cINFO. Groups of doctors in the UK and USA had been
Table 1: Pharmacological treatments and outcomes favoured by clinicians
Study Favored regimen Number of Doctors
USA 1999 [15] Haloperidol + lorazepam +/- benztropine 11/20
Droperidol 4/20
Benzodiazepine (unspecified) alone 3/20
Droperidol + lorazepam + diphenhydramine 1/20
Haloperidol + benztropine 1/20
Use of physical restraints
Common 14/20
Usually not used 6/20
Route of administration
Preferred IM or IV 14/20
Preferred IM 3/20
Unknown 3/20
UK 1994 [4] Chlorpromazine 14/28
Haloperidol 8/28
Haloperidol + chlorpromazine 2/28
Droperidol 1/28
'Neuroleptic' 1/28
Haloperidol + diazepam 1/28
Haloperidol + lorazepam 1/28
Desired end point
Sedated but mobile 12/28
Not sedated but calm 9/28
Asleep 7/28
Route of administration
Preferred IM 26/28
Preferred IV 2/28BMC Psychiatry 2002, 2 http://www.biomedcentral.com/1471-244X/2/4
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asked to list their preferred pharmacological management
of acutely aggressive patients. In the USA[3], medical di-
rectors of 20 psychiatric emergency rooms were asked
about their management of agitated patients. In the
UK[4], 28 psychiatrists were asked to give their opinion
on how a violent patient with a diagnosis of acute para-
noid psychosis should be pharmacologically managed.
The results of these surveys are shown in Table 1 and sug-
gest some similar patterns of drug preference but no con-
sistent favourite regimen.
Management preferred by clinicians, however, may not re-
flect real-world practice. We searched MEDLINE to identi-
fy surveys of Emergency Room practice. In 1989, a
prospective survey over 160 days was conducted in a ma-
jor psychiatric centre located in south London[12]. Pa-
tients were included if they had received an injection as an
acute treatment and during this period, 102 incidents
were reported. In France a similar survey was conducted
during 9 months in 1997[10]. Physical restraint by nurses
was used for 64% of people in the UK survey and for 86%
of agitated/violent attendees at the French emergency
room in Rouen. The results of these two surveys are pre-
sented in Table 2.
In the UK, intravenous treatments were common, and the
doses employed, high. In France, where aggression due to
intoxication was common, loxapine IM was largely used.
Other less informative surveys were identified[15].
About one percent of people suffer from schizophre-
nia[7]. Over 80% of those people live in low to middle in-
come countries[13]. In global terms, therefore, by far the
greatest burden of care of people with schizophrenia falls
to those in low and middle-income countries[20]. People
whose illness precipitates aggressive or violent behavior
are unlikely to be very rare in these societies, so it is rea-
sonable to assume that most psychosis-related aggression
is being managed in the developing world. Recognizing
this, and that the evidence-base of management is weak,
the authors undertook a survey of practice as a prelimi-
nary phase of a large, pragmatic randomised trial. This pa-
per reports a survey of drug management of severely
disturbed behavior, undertaken in one week in March
2000 in the Psychiatric Emergency Units of Rio de Janeiro,
Brazil.
Table 2: Studies of clinical practice
Ratio of means of 
administration IV 
: IM
Drug of choice Frequency 
of use
mean dose 
in mg 
(range)
Second 
injection
Complications / comments
UK 
1992[3]
1:1 Diazepam (Most frequent) 27 (10–80) 26% 1 hypotension
Haloperidol Њ 22 (10–60) 1 cardiorespitory arrest (60 mg 
haloperidol + 80 mg DZ)
Chlorpromazine | 162 (50–400) 1 tachycardia, 1 hypotension
Droperidol | 14 (10–20) 26%
Paraldehyde | 1 respiratory distress
Amytal
Lorazepam Ћ
Nitrazepam (Least frequent)
France 
1999
[10]
0:80 Loxapine 80% 200 mg 6% 2 with acute dystonia
Droperidol 5%
Chlorazepate 5% Mostly people with substance abuse 
(study in General Emergency Room)
Cyamemazine 6%
Diazepam < 2%
Sultopride
MeprobamateBMC Psychiatry 2002, 2 http://www.biomedcentral.com/1471-244X/2/4
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The county of Rio de Janeiro has about 5.8 m habitants
and four public hospitals are responsible for the care of
about 70% of the population (Hospital Phillippe Pinel,
Centro Psiquiátrico Rio de Janeiro, Centro Psiquiátrico
Pedro II, Hospital Jurandir Manfredini).
Materials and Methods
The period of the survey covered emergency consultations
from Saturday 25th March 2000 to Friday 31st March
2000, inclusive.
Data collection is difficult because information is record-
ed differently in each institution and electronic data are
not available. The principle researcher repeatedly visited
the emergency rooms and short stay wards of the hospitals
and collected data on everyone who had presented for an
emergency consultation during the prevalence period.
Emergency room notes were also inspected and medical
records sought for additional information on use of emer-
gency intramuscular sedation. The main focus of this
work the management of disturbed people who were like-
ly to suffer from a psychotic illness. Therefore, whenever a
primary diagnosis of substance abuse had been made,
data were not recorded.
Results
It was impossible to be confident that the records of use
of intramuscular (IM) medication for the 133 people who
attended the emergency room of Hospital Jurandir Man-
fredini were accurate, so data are not presented. Between
3% and 15% of medical notes were not available in the
other hospitals, so it was not possible to know if those
people were also given emergency sedation (Table 3).
During the seven-day period 764 patients attended the
emergency room in the three hospitals and at least 74 re-
ceived emergency sedative intramuscular drugs for psychi-
atric conditions that were not clearly induced by abuse of
substances. All 74 patients were thought to be suffering
from a psychotic illness at the time of sedation but follow
up was not possible to confirm the initial impression. No
patient received intravenous sedation and no patient re-
ceived extra doses. The total proportion of those receiving
IM sedation was similar among the three hospitals (8–
11%). Data on the use of physical restraints were not re-
corded but it is likely that a high proportion of people
were subject to four-point restraint, as this is standard
practice in these hospitals. Seclusion was not an option
and attempts at talking down were attempted for every-
one.
The drugs of choice for IM sedation in the three hospitals
in Rio de Janeiro are shown in Table 4. A haloperidol-pro-
methazine mix was the most popular combination and
was used in over 60% of episodes. This proportion
reached 83% if we include haloperidol-promethazine
plus other drugs.
Discussion
Surveys of the emergency sedation of acutely disturbed
people with serious mental illness are rare. They are diffi-
cult to undertake involve piecing together particularly
fragmented records and combining these data with the re-
cent memories of the relevant health professionals. In a
Developing World environment this process may be even
more problematic with vastly under-resourced services
and fully paper-based record keeping of varying stand-
ards.
For a population of about 3.5 m covered by the three hos-
pitals, we estimate that at least 74 people per week are se-
dated for disturbed behavior thought to be the result of
Table 3: Numbers attending for emergency care between 25th – 31st March at three hospitals in Rio de Janeiro
Hospital H.P.Pinel C.P.R.J. C.P.P.II
Emergency 
consultation
Given IM Missing Data Emergency 
consultation
Given IM Missing data Emergency 
consultation
Given IM Missing data
Sat 25th 25 9 1 16 4 0 24 3 2
Sun 26th 22 0 2 16 6 1 27 10 3
Mon 27th 56 4 3 47 3 0 46 2 6
Tue 28th 46 6 3 30 2 1 44 5 5
Wen 29th 46 4 2 20 0 1 51 3 7
Thu 30th 52 7 3 30 2 2 38 1 3
Fri 31th 46 2 3 31 1 0 61 0 18
Total 293 32 17 180 18 5 291 24 44BMC Psychiatry 2002, 2 http://www.biomedcentral.com/1471-244X/2/4
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serious mental illness. Eventually, a proportion of this
group may not have been diagnosed as having had psy-
chotic illness. The authors suspect, that however, because
the emergency rooms are only used for psychiatric crises,
and as the authors tried to screen out those suspected of
abusing substances,  the proportion not suffering from a
psychotic illness would be very small.
According to these figures, acute sedation for this group in
Rio de Janeiro seems to be less prevalent than in central
London (Brazil 2.1/week/100,000 vs London 3.3/week/
100,000)[12]. There may be many reasons for this dis-
crepancy and the authors would not wish to read too
much into these findings.
Emergency treatment, however, does seem more consist-
ent in Rio de Janeiro than in London. Eighty three percent
of patients receiving any drug for sedation in the emergen-
cy room of these hospitals were given promethazine in ad-
dition to haloperidol. Brazilian clinicians consider this
approach both safe and efficient. The rational for this
combination lies in the will to swiftly instigate antipsy-
chotic drugs, and in the sedative and antimuscarinic prop-
erties of promethazine. Doses of promethazine are
usually between 25–50 mg but, as adjunctive sedative for
emergency use, could reach 100 mg IM. The onset of ac-
tion is about 1–2 hours after intramuscular administra-
tion and half-life is 5–14 hours. The main adverse
reactions of promethazine are gastrointestinal disturbanc-
es, dry mouth and blurred vision.[18] Paradoxical reac-
tions such as CNS stimulation and extrapyramidal
symptoms have been reported, but are exceedingly rare.
Despite the high prevalence of use in Brazil, and we have
now been alerted to wide use in the Indian Sub-continent,
the authors have been unable to find any randomised
studies evaluating the use of haloperidol-promethazine
mix IM in the psychiatric emergency.
Conclusions
From the global perspective, current use of drugs in the
psychiatric emergency is varied [1]. Expert consensus dif-
fers, and systematic reviews of the best evidence produce
equivocal results[6]. Brazilian psychiatrists are consistent
in favouring use of IM haloperidol-promethazine for peo-
ple who are dangerously aggressive due to psychotic ill-
nesses, but recognize that authority to recommend the use
of this combination has to be supported by well-designed,
conducted and reported randomized trials. The TREC
study (Tranquilização Rápida-Ensaio Clínico), comparing
haloperidol-promethazine IM with a benzodiazepine,
now running in Brazil and India, is one such trial (proto-
col available from corresponding author).
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